序号 |
标题 |
次数 |
作者 |
发布时间 |
84196 |
CMCTS-SS-C16 含脂肪链的还原响应两亲性壳聚糖 |
153 |
h |
2024-11-22 |
84197 |
C16-SS-PEG/DMMA,棕榈酸-二硫键-聚乙二醇-甲基丙烯酸甲酯单体 |
154 |
h |
2024-11-22 |
84198 |
dota-ingr DOTA耦合新生血管靶向肽iNGR dota-gggcrngrgpdc |
88 |
zcy |
2024-11-22 |
84199 |
DOTA-GGG-TMVP1 DOTA修饰GGG-TMVP1靶向肽 |
120 |
zcy |
2024-11-22 |
84200 |
PL-A2-DOTA-Gd 天冬氨酸-亮氨酸共聚物偶联钆-1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(Gd-DOTA) |
95 |
zcy |
2024-11-22 |
84201 |
Pteroyl-lys-DOTA DOTA修饰蝶酰赖氨酸 |
97 |
zcy |
2024-11-22 |
84202 |
靶向VEGF载PTX聚合物纳米粒 Target PTX-loaded nanoparticles TPN |
145 |
zcy |
2024-11-22 |
84203 |
DOTA-PEG(12)-TFP*2TFA |
93 |
kx |
2024-11-22 |
84204 |
gadolinium Cy(2)DOTA |
77 |
kx |
2024-11-22 |
84205 |
NOTA-E(cRGDfK)2双功能螯合物 |
102 |
zyl |
2024-11-22 |
84206 |
DOTA-D-Glu-Ala-Tyr-Gly-Trp-(N-Me)Nle-Asp-1Nal-NH2 |
102 |
kx |
2024-11-22 |
84207 |
多肽化合物DOTA-RGD |
108 |
zyl |
2024-11-22 |
84208 |
DOTA-DG 葡萄糖胺-1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 |
128 |
zcy |
2024-11-22 |
84209 |
CAS:1426155-87-4, CU-64 DOTA-TATE |
104 |
kx |
2024-11-22 |
84210 |
氰基-半胱氨酸(CN-Cys) |
126 |
zcy |
2024-11-22 |
84211 |
DOTA-ubiquicidin (29–41) |
105 |
kx |
2024-11-22 |
84212 |
p-NO2-Bn-DOTA,116052-88-1 |
109 |
zyl |
2024-11-22 |
84213 |
C18烷基链-超支化聚甘油接枝p-环糊精两亲性聚阳离子囊泡 C18-γ-CD-HPG |
114 |
h |
2024-11-22 |
84214 |
TM-DOTA |
94 |
kx |
2024-11-22 |
84215 |
v6肽-NHCO-PEG-NHCO棕榈酰胺两亲性聚合物(v6-PEG-C16) |
135 |
h |
2024-11-22 |
84216 |
DOTA-NHS-ester,170908-81-3 |
103 |
zyl |
2024-11-22 |
84217 |
DOTA-Tyr-Lys-DOTA |
111 |
kx |
2024-11-22 |
84218 |
DOTA-peptide DOTA修饰磷酸化环腺苷酸应答元件结合蛋白(多肽) |
129 |
zcy |
2024-11-22 |
84219 |
功能性聚合物脂质 polyethylene glycol-Gly-Leu-Phe-Gly-Lys(C16)2) |
95 |
h |
2024-11-22 |
84220 |
DOTA-Colchicine |
95 |
zyl |
2024-11-22 |
84221 |
BAC14聚肌氨酸叠氮化物 BAC14-polysarcosine-Azide |
203 |
h |
2024-11-22 |
84222 |
CAS:204318-14-9,依多曲肽,DOTA-(Tyr3)-Octreotide acetate salt |
111 |
kx |
2024-11-22 |
84223 |
PEG-P(C16, BLA) 十六烷基聚(乙二醇)-聚(β-苄基l-天冬氨酸) |
148 |
h |
2024-11-22 |
84224 |
DOTA-PLL的介绍 |
122 |
zyl |
2024-11-22 |
84225 |
DOTA-E-[cyclo(RGDfK(Acp))]2 |
102 |
kx |
2024-11-22 |
84226 |
DOTA-Biotin DOTA-生物素 |
102 |
zyl |
2024-11-22 |
84227 |
DOTA-ZHER2:342(Cys39) 大环DOTA修饰anti-EGFR亲和体分子 |
88 |
zcy |
2024-11-22 |
84228 |
C16-PEG(2000Da)-Ceramide,C16 PEG2000神经酰胺 |
209 |
h |
2024-11-22 |
84229 |
DOTA-PEG-DBCO 点击化学聚乙二醇大环配体 |
95 |
zyl |
2024-11-22 |
84230 |
CAS:834870-39-2, 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, 10-(2,3,4,5,6-pentafluorophenyl) ester |
95 |
kx |
2024-11-22 |
84231 |
PSI-mPEG-C16 聚琥珀酰亚胺-甲氧基聚乙二醇-十六胺 |
171 |
h |
2024-11-22 |
84232 |
羧基化聚乙二醇单甲醚(mPEG-COOH) |
144 |
zcy |
2024-11-22 |
84233 |
cas:2032239-75-9|Maleimido-mono-amide-DTPA|马来酰亚胺单酰胺-DTPA |
123 |
zyl |
2024-11-22 |
84234 |
GdHPDO3A-C16,具有C16烷基链的HPDO3A配体 |
149 |
h |
2024-11-22 |
84235 |
819869-77-7,DOTA-(COOt-Bu)3-NHS,DOTA-三叔丁酯活性酯 |
101 |
zyl |
2024-11-22 |
84236 |
Gd-DOTA-AGCMC6 大分子多糖阿拉伯半乳聚糖修饰的DOTA钆配合物 |
95 |
zcy |
2024-11-22 |
84237 |
Gd-DOTA(M-147)的主要组成成分及功能 |
128 |
kx |
2024-11-22 |
84238 |
DOTA-RGD tetramer DOTA偶联RGD四聚体 |
100 |
zcy |
2024-11-22 |
84239 |
cas:1262403-90-6 DOTA-Val-Leu-Ala-Ser-Ser-Ala-Arg-COOH |
92 |
zyl |
2024-11-22 |
84240 |
Cd-Aminobenzyl-EDTA-KLH 齐岳定制 |
106 |
zcy |
2024-11-22 |